| Literature DB >> 30375482 |
Ana Carolina B Terzian1, Nathalia Zini1, Lívia Sacchetto2, Rebeca Froes Rocha3, Maisa Carla Pereira Parra1, Juliana Lemos Del Sarto3, Ana Carolina Fialho Dias3, Felipe Coutinho3, Jéssica Rayra3, Rafael Alves da Silva1, Vivian Vasconcelos Costa3, Natália Coelho Couto De Azevedo Fernandes4, Rodrigo Réssio4, Josué Díaz-Delgado4, Juliana Guerra4, Mariana S Cunha4, José Luiz Catão-Dias5, Cintia Bittar6, Andréia Francesli Negri Reis7, Izalco Nuremberg Penha Dos Santos7, Andréia Cristina Marascalchi Ferreira7, Lilian Elisa Arão Antônio Cruz7, Paula Rahal6, Leila Ullmann8, Camila Malossi8, João Pessoa de Araújo8, Steven Widen9, Izabela Maurício de Rezende2, Érica Mello10, Carolina Colombelli Pacca11, Erna Geessien Kroon2, Giliane Trindade2, Betânia Drumond2, Francisco Chiaravalloti-Neto12, Nikos Vasilakis13, Mauro M Teixeira3, Maurício Lacerda Nogueira14.
Abstract
In Africa, Old World Primates are involved in the maintenance of sylvatic circulation of ZIKV. However, in Brazil, the hosts for the sylvatic cycle remain unknown. We hypothesized that free-living NHPs might play a role in urban/periurban ZIKV dynamics, thus we undertook an NHP ZIKV investigation in two cities in Brazil. We identified ZIKV-positive NHPs and sequences obtained were phylogenetically related to the American lineage of ZIKV. Additionally, we inoculated four C. penicillata with ZIKV and our results demonstrated that marmosets had a sustained viremia. The natural and experimental infection of NHPs with ZIKV, support the hypothesis that NHPs may be a vertebrate host in the maintainance of ZIKV transmission/circulation in urban tropical settings. Further studies are needed to understand the role they may play in maintaining the urban cycle of the ZIKV and how they may be a conduit in establishing an enzootic transmission cycle in tropical Latin America.Entities:
Mesh:
Year: 2018 PMID: 30375482 PMCID: PMC6207778 DOI: 10.1038/s41598-018-34423-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Non-human primates positive for Zika virus, by RT-qPCR.
| Sample ID | NHPs species | Organs (Ct value) | ||||||
|---|---|---|---|---|---|---|---|---|
| KIDNEY | BRAIN | SPLEEN | LUNG | LIVER | HEART | GONADS | ||
| PR 17/02 | n/a | n/a | 38.37 | n/a | n/a | n/a | n/a | |
| PR 17/03 | n/a | 37.65 | n/a | neg | neg | n/a | n/a | |
| PR 17/04 | 37.84 | neg | 38.37 | 38.37 | neg | 36.19 | n/a | |
| PR 17/05 | 38.19 | 36 | 35.14 | 36.37 | 37.88 | neg | n/a | |
| PR 17/06 | 37.96 | neg | 38.23 | neg | neg | n/a | n/a | |
| PR 17/07 | 38.18 | 37.71 | neg | 37.92 | neg | neg | n/a | |
| PR 17/08 | 35.98 | 34.44 | 38.91 | neg | neg | neg | n/a | |
| PR 17/11 | Neg | 37.36 | neg | neg | neg | neg | n/a | |
| PR 17/12 | 35.66 | 35.64 | neg | n/a | 37.27 | neg | n/a | |
| PR 17/13 | 35.57 | 32.31 | 37.13 | neg | 29.25 | neg | n/a | |
| PR 17/14 | Neg | 37.12 | 37 | neg | neg | neg | n/a | |
| PR 17/15 | Neg | neg | neg | neg | 37.51 | n/a | n/a | |
| PR 17/16 | 30.87 | 30.4 | 31.48 | 27.76 | 29.18 | 31.32 | n/a | |
| PR 17/17 | 31.66 | 31.13 | n/a | 31.75 | 32.13 | 30.36 | n/a | |
| PR 17/18 | 29.17 | 31.86 | 32.87 | 30.47 | 30.16 | 29.72 | n/a | |
| PR 17/19 | 32.65 | 32.38 | 31.4 | 31.89 | neg | 32.32 | n/a | |
| PR 17/20 | 34.68 | 31.11 | neg | 34.36 | neg | 34.41 | n/a | |
| PR 17/21 | 32.89 | 31.11 | 33.27 | 31.9 | 32.86 | 32.59 | n/a | |
| PR 17/22 | 29.11 | 31.86 | 30.68 | 34.06 | 31.56 | 34.47 | n/a | |
| PR 17/23 | Neg | neg | n/a | neg | neg | 37.85 | n/a | |
| PR 17/25 | 37.79 | neg | 34.75 | 37.28 | 36.44 | neg | n/a | |
| PR 17/26 | 37.69 | n/a | 35.94 | neg | neg | 36.97 | n/a | |
| PR 17/27 | 38.47 | neg | neg | neg | neg | neg | n/a | |
| MG 17/01 | n/a | n/a | n/a | n/a | 36.0 | n/a | n/a | |
| MG 17/02 | n/a | n/a | n/a | n/a | 33.9 | n/a | n/a | |
| MG17/15 | 27.1 | n/a | n/a | n/a | n/a | n/a | neg | |
| MG 17/16 | n/a | n/a | n/a | n/a | 35.3 | n/a | n/a | |
| MG17/30 | neg | n/a | n/a | n/a | 35.6 | n/a | 36.3 | |
| MG 17/31 | n/a | n/a | n/a | n/a | 35.9 | n/a | n/a | |
| MG 17/32 | n/a | n/a | n/a | n/a | 36.3 | n/a | n/a | |
| MG 17/45 | n/a | n/a | n/a | n/a | 35.6 | n/a | n/a | |
| MG 17/51 | n/a | n/a | n/a | n/a | 35.7 | n/a | n/a | |
|
| ||||||||
|
|
|
| ||||||
| 17/151 | 35.17 | |||||||
| 17/160 | 36.89 | |||||||
| 17/161 | 36.48 | |||||||
| 17/163 | 31.87 | |||||||
| 17/164 | 36.77 | |||||||
| 17/169 | 22.23 | |||||||
Positive samples and mosquitoes are indicated by the Ct (cycle threshold) value. n/a: not available. neg: negative. Samples collected in São José do Rio Preto (SP), from January to March 2017 are identified by PR followed by year and sample ID. Samples collected in Minas Gerais, from January to June 2017, are identified by MG followed by year and sample ID. Mosquitoes collected in São José do Rio Preto (SP), in the first trimester of 2017 are identified by year and sample ID.
Figure 1Geoprocessing map of the NHPs and mosquitoes captured in the Vila Toninho neighborhood. (A) Schematic representation of the area where mosquitoes are regularly collected in the Vila Toninho neighborhood. The hatched area represents the area where there is no specimen collection. The blue dots represent the collection points of the mosquitoes and the quantity of specimen collected. (B) Schematic representation of the collection points of the nine NHP found dead. The NHPs identified by ID PR 17-05, PR 17-15, PR 17–22, PR 17–23, PR 17–27 were analyzed and tested positive for ZIKV in one or more tissue samples and are represented by a red triangle. The black triangles represent the NHPs collected but not tested. (C) Satellite image of the Vila Toninho neighborhood. The boundary of the neighborhood is marked in white. Vegetation cover area can be seen in green surrounding the neighborhood. (D) Overlap of the area of the animals and mosquitoes collection. The ZIKV-positive PR 17–27 is overlapping with a ZIKV-positive Ae. aegypti mosquito pool. (E) Overlap of the areas of animas and mosquito collections with the presence of the DENV-positive Ae. aegypti mosquitoes (Vila Toninho satellite image by Google Earth Pro 7.3.1.4507 (64-bit) software. URL https://www.google.com/maps/@−20.84677,−49.34063,5682 m/data = !3m1!1e3). Map data: Google, 2018 DigitalGlobe.
Figure 2Molecular Phylogenetic analysis of Zika virus by the Maximum Likelihood method. The four strains obtained from NHPs (marmosets) are highlighted in red. Bootstrap values above 90% are shown. Initial tree(s) for the heuristic search were obtained automatically by applying Neighbor-Join and BioNJ algorithms to a matrix of pairwise distances estimated using the Maximum Composite Likelihood (MCL) approach, and then selecting the topology with superior log likelihood value. A discrete Gamma distribution was used to model evolutionary rate differences among sites (5 categories (+G, parameter = 1.7699)). The rate variation model allowed for some sites to be evolutionarily invariable ([+I], 52.6922% sites). The tree was drawn to scale, with branch lengths measured in the number of substitutions per site. There were a total of 10269 positions in the final dataset. Evolutionary analyses were conducted in MEGA7[64].
Histopathologic findings in 16 NHPs positive for Zika virus.
| Sample ID | Cerebrum | Heart | Lung | Liver | Spleen | Kidney |
|---|---|---|---|---|---|---|
| PR 17/03 | Autolysis | Autolysis | Autolysis | Autolysis | Autolysis | Autolysis |
| PR 17/04 | Autolysis | Autolysis | Mild multifocal suppurative bronchopneumonia; Intravascular microfilariae | Moderate multifocal chronic proliferative cholangitis with intralesional trematode ova and adults; Mild to moderate diffuse vacuolar (hydropic) hepatopathy; Intravascular microfilariae | Autolysis | Minimal focal lymphoplasmacytic interstitial nephritis |
| PR 17/05 | Congestion and multifocal acute hemorrhage. | Congestion and multifocal acute hemorrhage. | Multifocal acute alveolar hemorrhage | Multifocal random mononuclear inflammatory infiltrates and minimal pericholangitis; Mild diffuse vacuolar (hydropic) hepatopathy | Mild to moderate, diffuse sinus histiocytosis | Minimal multifocal acute tubular degeneration with mild proteinosis; Minimal focal chronic lymphocytic interstitial nephritis |
| PR 17/07 | NSLO | NSLO | Moderate to severe acute alveolar hemorrhage | Marked, diffuse vacuolar (hydropic) hepatopathy | Extramedullary hematopoiesis; Lymphoid reactive hyperplasia | Without NSLO |
| PR 17/08 | NE | Minimal multifocal chronic lymphocytic myocarditis | Marked multifocal acute alveolar and bronchial hemorrhage with edema and histiocytosis; Mild multifocal chronic lymphocytic and eosinophilic perivasculitis and mild lymphoid hyperplasia; Focal parabronchial arterial bone marrow embolus. | Congestion; Minimal, focal, chronic eosinophilic pericholangitis and minimal reactive changes. | Diffuse lymphoid reactive hyperplasia and sinus histiocytosis | Mild, multifocal tubular proteinosis; Congestion. |
| PR 17/11 | Multifocal acute cortical neuron necrosis | Congestion, edema and focal hemorrhage | Congestion, edema and focal hemorrhage | Moderate diffuse vacuolar (hydropic) hepatopathy | Diffuse lymphoid reactive hyperplasia | Moderate multifocal chronic membranous glomerulonephritis with lymphoid follicle formation |
| PR 17/12 | NSLO | NSLO | Moderate multifocal acute alveolar hemorrhage and edema | Moderate diffuse vacuolar (hydropic) hepatopathy; Moderate multifocal neutrophilic portal hepatitis | Mild diffuse lymphoid reactive hyperplasia | Congestion |
| PR 17/13 | Mild focal hemorrhage | Mild multifocal acute myocyte degeneration | Mild multifocal acute interstitial pneumonia | Marked multifocal chronic proliferative cholangiohepatitis with marked cholestasis and necrosis; Extramedullary hematopoiesis | Multifocal acute necrotizing splenitis; Extramedullary hematopoiesis. | NSLO |
| PR 17/14 | Congestion | NSLO | Moderate multifocal subacute interstitial pneumonia with bronchiolitis | NSLO | Moderate lymphoid depletion | NSLO |
| PR 17/15 | NE | NSLO | Autolysis | NSLO | NSLO | Mild multifocal chronic interstitial nephritis |
| PR 17/16 | Congestion | Minimal focal chronic lymphocytic infiltrate; Congestion | Diffuse atelectasia; Mild multifocal subacute suppurative bronchopneumonia | Mild multifocal chronic lymphocytic pericholangitis; Mild diffuse vacuolar (hydropic) hepatopathy | NE | Mild multifocal chronic lymphocytic interstitial nephritis; Mild multifocal acute tubular degeneration |
| PR 17/18 | Minimal focal lymphocytic vascular cuffing; Congestion and multifocal alveolar hemorrhage | Mild multifocal myocardial fibrosis; Mild multifocal acute myocyte degeneration with contraction band necrosis | Multifocal acute alveolar hemorrhage | Mild multifocal chronic eosinophilic and lymphoplasmacytic cholangitis with intraductal adult trematodes, bile duct hyperplasia and mild fibrosis | Mild diffuse lymphoid reactive hyperplasia and sinus histiocytosis | Mild multifocal chronic lymphoplasmacytic interstitial nephritis; Mild multifocal segmental membranous glomerulonephritis with proteinuria; Mild multifocal acute tubular necrosis |
| PR 17/19 | Multifocal acute hemorrhage and congestion. | NSLO | Congestion, edema and multifocal acute alveolar hemorrhage; Focal interstitial nodular lymphohistiocytic and eosinophilic infiltrate | Mild multifocal chronic lymphoplasmacytic pericholangitis | Diffuse lymphoid reactive hyperplasia and histiocytosis | Moderate diffuse global chronic membranoproliferative glomerulitis with moderate lymphoplasmacytic interstitial nephritis; Focal granuloma. |
| PR 17/20 | NE | NSLO | Locally extensive alveolar hemorrhage; Moderate focal acute suppurative bronchopneumonia | Mild diffuse vacuolar (hydropic) hepatopathy | NSLO | NSLO |
| PR 17/21 | Mild focal chronic lymphocytic meningitis | Congestion | Diffuse congestion, edema and atelectasia; mild alveolar hemosiderosis | Mild multifocal chronic lymphoplasmacytic and granulomatous pericholangitis with mild hemosiderosis; Mild multifocal acute single cell hepatocellular necrosis | Mild diffuse lymphoid reactive hyperplasia and mild sinus histiocytosis | Mild multifocal acute tubular degeneration with proteinosis e atrofia glomerulocística focal |
| PR 17/22 | NSLO | NSLO | Diffuse congestion, edema and multifocal acute hemorrhage; Multifocal atelectasia; Mild lymphoplasmacytic peribronchial and perivascular infiltrates with rare alveolar multinucleate giant cells | Mild multifocal chronic lymphoplasmacytic and eosinophilic cholangiohepatitis with moderate bile duct hyperplasia; Mild diffuse vacuolar (hydropic) hepatopathy | Moderate diffuse lymphoid reactive hyperplasia and sinus histiocytosis | Minimal multifocal chronic lymphoplasmacytic interstitial nephritis and rare glomerulocystic atrophy |
NSLO: no significant lesions observed; NE: not evaluated.
Figure 3Viremia measurement in experimentally ZIKV-infected Callithrix penicilata collected from day −1 until 19 dpi. One-step qRT-PCR was used to measure semi quantitatively the ZIKV RNA loads in the serum of four animals at indicated days p.i. and represented as viral RNA copies per mL of sample standard curve. The curve was obtained from a standard sample with known titer after serial dilutions (5 × 101 to 5 × 106 copies/mL) on the plasma of the non-infected marmosets.Values are expressed by RNA genome copies per mL for all the infected marmosets. Viremia was detected in the serum of marmosets 1, 3 and 4 on day 2 p.i. and in all infected marmosets on day 3 p.i. The figure shows that viremia increased on day 5 p.i. when compared to other evaluated days for all the infected marmosets. p.i.: post infection. NHP: non-human primates. Day −1: day before the infection.
Non-human primates viremia after ZIKV infection.
| Days | Animal | RNA copies/mL |
|---|---|---|
| −1 | NHP 1 | Negative |
| NHP 2 | Negative | |
| NHP 3 | Negative | |
| NHP 4 | Negative | |
| 0 | NHP 1 | 841,90 |
| NHP 2 | Negative | |
| NHP 3 | Negative | |
| NHP 4 | Negative | |
| 2 | NHP 1 | 200,01 |
| NHP 2 | Negative | |
| NHP 3 | 1075,95 | |
| NHP 4 | 204,24 | |
| 3 | NHP 1 | 1149,61 |
| NHP 2 | 213,74 | |
| NHP 3 | 237,92 | |
| NHP 4 | 2191,26 | |
| 4 | NHP 1 | 2848,23 |
| NHP 2 | 625,86 | |
| NHP 3 | 786,27 | |
| NHP 4 | 3295,71 | |
| 6 | NHP 1 | 19958,28 |
| NHP 2 | 1761,87 | |
| NHP 3 | 30199,58 | |
| NHP 4 | 4156,29 | |
| 9 | NHP 1 | 129,26 |
| NHP 2 | 216,64 | |
| NHP 3 | Negative | |
| NHP 4 | Negative | |
| 12 | NHP 1 | 579,66 |
| NHP 2 | 229,28 | |
| NHP 3 | Negative | |
| NHP 4 | 9840,11 | |
| 15 | NHP 1 | 2208,29 |
| NHP 2 | Negative | |
| NHP 3 | Negative | |
| NHP 4 | Negative | |
| 19 | NHP 1 | Negative |
| NHP 2 | 346,82 | |
| NHP 3 | Negative | |
| NHP 4 | Negative |
Figure 4ZIKV infection in Callithrix penicilata alters total leukocyte counts. The animals were followed for 28 days. The data represents the results obtained of a pooled sample from four marmosets prior to infection (day 0) and in different days post infection (dpi). The infection altered total leukocyte count in blood inducing leukocytosis 7 dpi and 21 dpi in a two-wave fashion. Results are presented as counts/mm3 per ml of blood.
Figure 5ZIKV infection in Callithrix penicilata alters hematocrit levels. The animals were followed for 28 days. The data represents the results obtained of a pooled sample from four marmosets prior to infection (day 0) and on different days post infection (dpi). No differences were observed in the hematocrit levels during the course of the infection. Results are presented as hematocrit percentage.
Figure 6IgG titers in Callithrix penicilata after ZIKV infection. To evaluate the adaptive immune response after ZIKV infection, plasma samples were evaluated on days 0 (prior to infection) and 2,3,4,5,8,9,12,15,19 and 60 d.p.i. by an indirect ELISA. The IgG titers peaked from day 9 to 12 p.i. in the serum of marmosets 1,2 and 3 and on day 15 p.i. in the serum of marmoset 2 when compared to the other evaluated days. IgG titers were detectable until day 19 p.i. in all marmosets.